Attitude and beliefs about the social environment associated with chemsex among MSM visiting STI clinics in the Netherlands: An observational study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
11
2019
accepted:
16
06
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
10
9
2020
Statut:
epublish
Résumé
Drug use during sex, 'chemsex', is common among men who have sex with men (MSM) and related to sexual and mental health harms. This study assessed associations between chemsex and a wide range of determinants among MSM visiting STI clinics to increase understanding of characteristics and beliefs of MSM practicing chemsex. In 2018, 785 MSM were recruited at nine Dutch STI clinics; 368 (47%) fully completed the online questionnaire. All participants reported to have had sex in the past six months. Chemsex was defined as using cocaine, crystal meth, designer drugs, GHB/GBL, ketamine, speed or XTC/MDMA during sex in the past six months. Associations between chemsex and psychosocial determinants, socio-demographics, sexual behaviour and using tobacco or alcohol were assessed by multivariable logistic regression analyses. Chemsex was reported by 44% of MSM (161/368) and was not associated with socio-demographics. Independent determinants were 'believing that the majority of friends/sex partners use drugs during sex' (descriptive norm) (aOR: 1.95, 95%CI: 1.43-2.65), 'believing that sex is more fun when using drugs' (attitude) (aOR: 2.06, 95%CI: 1.50-2.84), using tobacco (aOR: 2.65, 95%CI: 1.32-5.32), multiple sex partners (aOR: 2.69, 95%CI: 1.21-6.00), group sex (aOR: 4.65, 95%CI: 1.54-14.05) and using online dating platforms (aOR: 2.73, 95%CI: 1.13-6.62). MSM are likely to find themselves in distinct social networks where it is the norm to use drugs when having sex and pleasure is linked to chemsex. Health services should acknowledge the social influence and pleasurable experiences to increase acceptability of strategies aimed at minimizing the possible harms of chemsex.
Sections du résumé
BACKGROUND
Drug use during sex, 'chemsex', is common among men who have sex with men (MSM) and related to sexual and mental health harms. This study assessed associations between chemsex and a wide range of determinants among MSM visiting STI clinics to increase understanding of characteristics and beliefs of MSM practicing chemsex.
METHODS
In 2018, 785 MSM were recruited at nine Dutch STI clinics; 368 (47%) fully completed the online questionnaire. All participants reported to have had sex in the past six months. Chemsex was defined as using cocaine, crystal meth, designer drugs, GHB/GBL, ketamine, speed or XTC/MDMA during sex in the past six months. Associations between chemsex and psychosocial determinants, socio-demographics, sexual behaviour and using tobacco or alcohol were assessed by multivariable logistic regression analyses.
RESULTS
Chemsex was reported by 44% of MSM (161/368) and was not associated with socio-demographics. Independent determinants were 'believing that the majority of friends/sex partners use drugs during sex' (descriptive norm) (aOR: 1.95, 95%CI: 1.43-2.65), 'believing that sex is more fun when using drugs' (attitude) (aOR: 2.06, 95%CI: 1.50-2.84), using tobacco (aOR: 2.65, 95%CI: 1.32-5.32), multiple sex partners (aOR: 2.69, 95%CI: 1.21-6.00), group sex (aOR: 4.65, 95%CI: 1.54-14.05) and using online dating platforms (aOR: 2.73, 95%CI: 1.13-6.62).
CONCLUSION
MSM are likely to find themselves in distinct social networks where it is the norm to use drugs when having sex and pleasure is linked to chemsex. Health services should acknowledge the social influence and pleasurable experiences to increase acceptability of strategies aimed at minimizing the possible harms of chemsex.
Identifiants
pubmed: 32609770
doi: 10.1371/journal.pone.0235467
pii: PONE-D-19-31468
pmc: PMC7329118
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0235467Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Subst Abuse Treat. 2011 Oct;41(3):265-72
pubmed: 21550758
PLoS One. 2019 May 14;14(5):e0216732
pubmed: 31086390
Int J Drug Policy. 2019 Jan;63:74-89
pubmed: 30513473
Sex Health. 2018 Apr;15(2):116-122
pubmed: 29268074
Int J Drug Policy. 2016 Dec;38:29-35
pubmed: 27842251
Sex Transm Infect. 2019 Aug;95(5):342-350
pubmed: 30979782
Harm Reduct J. 2016 Dec 9;13(1):36
pubmed: 27938393
Sex Transm Infect. 2017 May;93(3):153-154
pubmed: 28108700
HIV Med. 2018 May 22;:
pubmed: 29790254
Int J Drug Policy. 2018 Nov;61:31-37
pubmed: 30388567
J Stud Alcohol Drugs. 2012 Jul;73(4):675-85
pubmed: 22630806
Sex Transm Dis. 2018 May;45(5):325-331
pubmed: 29465683
Lancet HIV. 2014 Oct;1(1):e22-31
pubmed: 26423813
Int J STD AIDS. 2018 Feb;29(2):128-134
pubmed: 28691863
HIV Med. 2018 Apr;19(4):261-270
pubmed: 29368440
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Int J STD AIDS. 2017 Mar;28(4):362-366
pubmed: 27178067
Int J Drug Policy. 2018 May;55:169-179
pubmed: 29429865
Int J Drug Policy. 2019 Feb;64:5-12
pubmed: 30513421
AIDS Res Ther. 2018 Oct 19;15(1):14
pubmed: 30340607
J Sex Med. 2019 May;16(5):721-732
pubmed: 30952548
Cult Health Sex. 2018 Apr;20(4):411-427
pubmed: 28741417
J Behav Med. 2013 Oct;36(5):488-97
pubmed: 22760451
Subst Use Misuse. 2019;54(6):944-954
pubmed: 30648480
Sex Health. 2018 Apr;15(2):151-156
pubmed: 29580377
Int J Drug Policy. 2018 May;55:231-241
pubmed: 29402683
J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
Sex Transm Infect. 2017 May;93(3):203-206
pubmed: 27519259
Int J Drug Policy. 2018 Feb;52:9-15
pubmed: 29223761
Sex Health. 2018 Apr;15(2):144-150
pubmed: 29592829